Results 171 to 180 of about 212,304 (319)

Optimization of bioactive compounds extraction from Rosa canina L. pseudofruit through the action of two hydrolytic enzyme preparations

Journal of Chemical Technology &Biotechnology, EarlyView.
Abstract BACKROUND The pseudo‐fruit of Rosa canina L. is a rich source of bioactive compounds with antioxidant, anti‐inflammatory, anti‐cancer, anti‐diabetic, anti‐aging, and antimicrobial activities. The aim of the present study is the optimization of a green process based on the action of two hydrolytic enzyme preparations, namely Pectinex® Ultra ...
Zafeiria Lemoni, Styliani Kalantzi, Theopisti Lymperopoulou, Andromachi Tzani, Georgios Stavropoulos, Anastasia Detsi, Diomi Mamma   +6 more
wiley   +1 more source

Mergers and Innovation in the Pharmaceutical Market [PDF]

The U.S. pharmaceutical industry has experienced in recent years two dramatic changes: stagnation in the growth of new molecular entities approved for marketing, and a wave of mergers linking inter alia some of the largest companies.
Comanor, William S., Scherer, F. M.
core   +1 more source

The impact of physical activity on psychological distress in young people: An analysis of longitudinal data from the Millennium Cohort Study using causal machine learning

JCPP Advances, EarlyView.
Using causal machine learning, we estimated the causal effect of meeting government guidelines on physical activity on psychological distress in young people. Whilst observing no overall impact, we did identify some groups who benefit relatively more from meeting the physical activity guidelines, including males.
Lewis W. Paton, Noemi Kreif, Lauren M. E. Aylott, Philip Kerrigan, Clau Nader, Lina Gega, Paul A. Tiffin   +6 more
wiley   +1 more source

Global mechanisms to improve affordability of high-priced medicines: the role of the WHO model lists of essential medicines. [PDF]

J Pharm Policy Pract
Jenei K.
europepmc   +1 more source

Does Public Scientific Research Complement Industry R&D Investment? The Case of NIH Supported Basic and Clinical Research and Pharmaceutical Industry R&D [PDF]

This research investigates the hypothesis that publicly funded scientific research complements private R&D investment in the pharmaceutical industry. New microlevel data on public research investment by the U.S.
Toole, Andrew A.
core  

Correlates of Help‐Seeking Behaviour in a Low‐Income Country: A Focus on Children's and Women's Outcomes

Journal of International Development, EarlyView.
ABSTRACT In developing countries, where access to markets and services is limited, poor households often rely on social networks for support. We examine the correlates and outcomes of help‐seeking behaviour among impoverished households in Uganda. We use micro‐household data from the Living Standard Measurement Study—Integrated Surveys on Agriculture ...
Yuanhang Wang, Kashi Kafle, Shahriar Kibriya   +2 more
wiley   +1 more source

The impact of patent activity on idiosyncratic volatility in U.S. pharmaceutical companies. [PDF]

PLoS One
Atilgan E, Türkmen Ceylan FB, Doruk ÖT, Ertuğrul HM, Barak AY.   +4 more
europepmc   +1 more source

When Does Top Management Team Diversity Matter in Large Organizations?

Journal of Organizational Behavior, EarlyView.
ABSTRACT Top management teams (TMTs) drive strategic leadership, but there is little clarity on when the composition of these upper echelons most impacts organization performance. Drawing from the categorization‐elaboration model, we study an 18‐year sample of approximately 4500 organizations and over 32 000 executives and find a positive relationship ...
Frances Fabian, James M. Plečnik, Shan Wang   +2 more
wiley   +1 more source

Impact of combined medication payment management policies on population health performance. [PDF]

PLoS One
Duan D, Yang Y.
europepmc   +1 more source

Pharmaceutical economics and health policy research using administrative data

, 2004
Alan Lyles
openalex   +1 more source